BC-CfE published a landmark paper on “The case for expanding access to highly active antiretroviral therapy to curb the growth of the epidemic” (Lancet 2006; 368: 531-36). Since then, BC-CfE has gained the endorsement of the provincial government to roll out such a program in BC.
HIV Ward expanded to 24 beds. Since its opening in 1997, there have been approximately 400 annual admissions.
IDC introduced the post-exposure prophylaxis clinic to provide support to patients requiring more extensive counseling and/or support and for patients without a source of primary care.
CLICK FOR NEW HIV-1 RESISTANCE GENOTYPE REPORT NOTICE
The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’. For more details and example reports, please click on the button below
